Balentine LLC’s Chemours CC Stock Holding History

Balentine LLC’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-92	Closed	-$5K	–	137
2017 Q4	$5K	Hold	92	–	–	﹤0.01%	510
2017 Q3	$5K	Hold	92	–	–	﹤0.01%	510
2017 Q2	$3K	Hold	92	–	–	﹤0.01%	529
2017 Q1	$4K	Hold	92	–	–	﹤0.01%	480
2016 Q4	$2K	Buy	+92	New	+$1.89K	﹤0.01%	473

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Balentine LLC's CC Position: Q1 2018 in Review

Balentine LLC sold out of Chemours (CC) in Q1 2018, closing a stake of 92 shares — an estimated $5K sold.

Balentine LLC first reported a position in CC in Q4 2016 and held it in 5 quarters. The position peaked at $5K in Q4 2017. 546 funds tracked by Wall St. Rank hold CC as of Q1 2018.

Balentine LLC reported no remaining Chemours position as of Q1 2018 after selling out during the quarter.
Balentine LLC sold 92 Chemours shares in Q1 2018, an estimated $5K.
Balentine LLC first reported a position in Chemours in Q4 2016 and held it in 5 quarters.
Balentine LLC's Chemours position peaked at $5K in Q4 2017.
546 funds tracked by Wall St. Rank held Chemours as of Q1 2018.

Based on Balentine LLC's 13F filing for Q1 2018, filed 16 May 2018.